No. 22-1180

Shire U.S., Inc., et al. v. Mark Blackburn

Lower Court: Eleventh Circuit
Docketed: 2023-06-07
Status: Denied
Type: Paid
Amici (1) Experienced Counsel
Tags: drug-labeling fda-preapproval FDA-regulations federal-preemption pliva-v-mensing preemption prescription-drugs state-law-claim state-law-claims unilateral-change unilateral-label-changes
Latest Conference: 2023-09-26
Question Presented (from Petition)

Whether a state-law claim is preempted if it places a duty on a drug manufacturer to unilaterally change FDA-approved language that appears in the Highlights section of a drug label.

Question Presented (AI Summary)

Whether a state-law claim is preempted if it places a duty on a drug manufacturer to unilaterally change FDA-approved language that appears in the Highlights section of a drug label

Docket Entries

2023-10-02
Petition DENIED.
2023-07-26
DISTRIBUTED for Conference of 9/26/2023.
2023-07-26
2023-07-12
2023-07-07
Brief amicus curiae of Pharmaceutical Research Manufacturers of America filed.
2023-06-23
Motion to extend the time to file a response is granted and the time is extended to and including August 7, 2023.
2023-06-22
Motion to extend the time to file a response from July 7, 2023 to August 7, 2023, submitted to The Clerk.
2023-06-02
2023-04-25
Application (22A846) granted by Justice Thomas extending the time to file until June 4, 2023.
2023-04-18
Application (22A846) to extend further the time from May 5, 2023 to June 4, 2023, submitted to Justice Thomas.
2023-03-29
Application (22A846) granted by Justice Thomas extending the time to file until May 5, 2023.
2023-03-21
Application (22A846) to extend the time to file a petition for a writ of certiorari from April 5, 2023 to May 5, 2023, submitted to Justice Thomas.

Attorneys

Mark Blackburn
Allison M. ZievePublic Citizen Litigation Group, Respondent
Pharmaceutical Research Manufacturers of America
Michael Xavier ImbroscioCovington and Burling LLP, Amicus
Shire US Inc., et al.
Erin E. MurphyClement & Murphy, PLLC, Petitioner